The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2016
Filed:
Oct. 07, 2013
Applicant:
Italfarmaco Spa, Milan, IT;
Inventors:
Tiziano Oldoni, Rho, IT;
Paolo Mascagni, Villasanta, IT;
Alessandro Rambaldi, Bergamo, IT;
Tiziano Barbui, Bergamo, IT;
Assignee:
ITALFARMACO SPA, Milan, IT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); A61K 31/16 (2006.01); A61K 31/167 (2006.01); A61K 45/06 (2006.01); A61K 31/18 (2006.01);
U.S. Cl.
CPC ...
A61K 31/167 (2013.01); A61K 31/00 (2013.01); A61K 31/16 (2013.01); A61K 31/18 (2013.01); A61K 45/06 (2013.01);
Abstract
Method of treating Philadelphia-negative myeloproliferative syndromes in a patient suffering from such syndromes. The method is carried out by administering to the patient diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl -methyl]-ammonium chloride, or other pharmaceutically acceptable salts and/or solvates, in a daily dosage amount of from 10 to 150 mg per patient.
Oldoni, Tiziano. (2016). Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes (U.S. Patent No. 9522127). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9522127
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile